These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 571022)

  • 21. [Low molecular weight heparins].
    Kher A; Bara L; Samama M
    Pathol Biol (Paris); 1986 Jan; 34(1):61-9. PubMed ID: 3517772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP
    J Pharmacol Exp Ther; 1982 Feb; 220(2):406-10. PubMed ID: 7057400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Lung Heparin and Porcine Intestine Heparin.
    Guan Y; Xu X; Liu X; Sheng A; Jin L; Linhardt RJ; Chi L
    J Pharm Sci; 2016 Jun; 105(6):1843-1850. PubMed ID: 27238483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparins: varying effects on cell proliferation in vitro and lack of correlation with anticoagulant activity.
    Lippman MM; Mathews MB
    Fed Proc; 1977 Jan; 36(1):55-9. PubMed ID: 830557
    [No Abstract]   [Full Text] [Related]  

  • 25. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Physico-chemical characteristics of heparin in relation to its anticoagulant and anti-hemostatic action].
    Nader HB; Dietrich CP; Straus AH; Takahashi HK
    Rev Bras Biol; 1979 Nov; 39(4):793-816. PubMed ID: 162073
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
    Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
    Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural features and anticoagulant activities of a novel natural low molecular weight heparin from the shrimp Penaeus brasiliensis.
    Dietrich CP; Paiva JF; Castro RA; Chavante SF; Jeske W; Fareed J; Gorin PA; Mendes A; Nader HB
    Biochim Biophys Acta; 1999 Aug; 1428(2-3):273-83. PubMed ID: 10434045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bovine and porcine heparins: different drugs with similar effects on human haemodialysis.
    Tovar AM; Teixeira LA; Rembold SM; Leite M; Lugon JR; Mourão PA
    BMC Res Notes; 2013 Jun; 6():230. PubMed ID: 23763719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative activities of heparin fractions obtained by gel chromatography.
    Graham DT; Pomeroy AR
    Thromb Haemost; 1980 Feb; 42(5):1598-603. PubMed ID: 7368160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping and quantification of the major oligosaccharide components of heparin.
    Linhardt RJ; Rice KG; Kim YS; Lohse DL; Wang HM; Loganathan D
    Biochem J; 1988 Sep; 254(3):781-7. PubMed ID: 3196292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standard and method independent units for heparin anticoagulant activities.
    Hemker HC; Béguin S
    Thromb Haemost; 1993 Nov; 70(5):724-8. PubMed ID: 8128425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential activities of heparins in human plasma and in sheep plasma. Effects of heparin molecular sizes and sources.
    Shen LL; Barlow GH; Holleman WH
    Thromb Res; 1978 Oct; 13(4):671-9. PubMed ID: 570738
    [No Abstract]   [Full Text] [Related]  

  • 34. [The new heparins].
    Samama M
    Presse Med; 1986 Sep; 15(32):1631-5. PubMed ID: 2949211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulant activity of whale intestine heparin and its clinical application.
    Abe T; Kazama M; Matsuda M; Ikemori R; Shibata T
    Bibl Haematol; 1968; 29():1141-9. PubMed ID: 5750138
    [No Abstract]   [Full Text] [Related]  

  • 36. Isolation of low-molecular-weight heparin/heparan sulfate from marine sources.
    Saravanan R
    Adv Food Nutr Res; 2014; 72():45-60. PubMed ID: 25081076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of heparin activity by a new laser nephelometric method and comparison to the USP method.
    Escobar A; Maher RT; Courtney ML; Valicenti AJ
    J Pharm Sci; 1984 Nov; 73(11):1640-2. PubMed ID: 6520771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C.
    Fernández JA; Petäjä J; Griffin JH
    Thromb Haemost; 1999 Nov; 82(5):1462-8. PubMed ID: 10595639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical microdetermination of heparin in plasma.
    Toida T; Huang Y; Washio Y; Maruyama T; Toyoda H; Imanari T; Linhardt RJ
    Anal Biochem; 1997 Sep; 251(2):219-26. PubMed ID: 9299019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biological and HPLC analysis of heparin after thermal treatment].
    Pintabona A; Bottazzi A; Capra R
    Boll Chim Farm; 1991 Dec; 130(11):439-42. PubMed ID: 1809297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.